Guidance

Update information

Update information

April 2017: We updated the recommendation on corticosteroid treatment for alcohol-related hepatitis. This recommendation is marked as [2017].

Some changes were made to recommendation wording without an evidence review. These recommendations are marked as [2010, amended 2017]. The changes are:

  • We removed olanzapine from recommendation 1.1.4.1 because the formulation is no longer available.

  • We removed a note from recommendation 1.3.2.1 because the nationally agreed guidelines for liver transplant assessment in the context of alcohol-related liver disease are no longer available online.

Recommendations are marked as [2010] when the evidence was last reviewed in 2010.

Minor changes since publication

December 2024: In September 2024, supplies of pancreatic enzyme replacement therapy were disrupted, so availability varies. The latest information on prescribing and ordering was added to the section on enzyme supplementation for chronic alcohol-related pancreatitis.

October 2022: We replaced recommendations on surgery for people with pain from large-duct (obstructive) chronic alcohol-related pancreatitis, prophylactic antibiotics for acute alcohol-related pancreatitis, and nutritional support for acute alcohol-related pancreatitis with recommendations from NICE's guideline on pancreatitis. These recommendations are marked as [2018]. We also added a cross reference in the section on alcohol related liver disease to NICE's guideline on cirrhosis in over 16s.

May 2021: We linked to the updated MHRA safety advice on antiepileptic drugs in pregnancy in recommendation 1.1.3.1.

August 2019: We updated the glossary definitions and terminology for harmful drinking and hazardous drinking in line with the UK chief medical officers' low risk drinking guidelines.

ISBN: 978-1-4731-2477-6